From: 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting
Low tertile | Central tertile | High tertile | p | |
---|---|---|---|---|
Gender (N = 434) | ||||
Male | 81 (28.7%) | 97 (34.4%) | 104 (36.9%) | 0.312 |
Female | 48 (31.6%) | 59 (38.8%) | 45 (36.9%) | |
Age (years) (N = 423) | ||||
< 50 | 69 (35.6%) | 76 (39.2%) | 49 (25.2%) | < 0.01 |
> 50 | 54 (23.6%) | 78 (34.0%) | 97 (42.4%) | |
BMI kg/m2 (N = 251) | ||||
< 25 | 49 (42.6%) | 44 (38.3%) | 22 (21.7%) | < 0.01 |
25–30 | 10 (12%) | 26 (32%) | 45 (56%) | |
≥ 30 | 10 (18%) | 15 (27%) | 30 (55%) | |
AST (IU/L) (N = 397) | ||||
< 50 | 89 (42.2%) | 69 (32.7%) | 53 (25.1%) | < 0.01 |
≥ 50 | 39 (21%) | 68 (36.5%) | 79 (42.5%) | |
Total bilirubin (µmol/L) (N = 404) | ||||
< 20 | 109 (38.6%) | 109 (38.6%) | 64 (22.8%) | < 0.01 |
≥ 20 | 24 (19.7%) | 32 (26.2%) | 66 (54.1%) | |
Cause of CLD | ||||
ALD | 6 (9.7%) | 17 (27.4%) | 39 (62.9%) | |
HBV | 60 (56%) | 28 (26%) | 20 (18%) | |
HCV | 36 (31%) | 43 (32%) | 37 (32%) | < 0.01 |
NAFLD | 17 (24.6%) | 23 (33.3%) | 29 (42%) | |
Other | 31 (32%) | 41 (42%) | 25 (26%) | |
Fibrosis stage | ||||
F0 | 37 (51%) | 20 (28%) | 15 (21%) | |
F1 | 46 (44.5%) | 45 (44.5%) | 12 (11%) | |
F2 | 30 (42%) | 27 (37%) | 15 (21%) | < 0.01 |
F3 | 18 (33%) | 20 (37%) | 16 (30%) | |
F4 | 16 (11%) | 44 (29%) | 91 (60%) | |
Steatosis (303) | ||||
S0 | 41 (29.3%) | 56 (40.0%) | 43 (30.7%) | |
S1 | 20 (24.4%) | 36 (43.9%) | 26 (31.7%) | 0.707 |
S2 | 18 (30.0%) | 24 (40.0%) | 18 (30.0%) | |
S3 | 9 (42.9%) | 5 (23.8%) | 7 (33.3%) | |
First LSM | ||||
< 7.1 kPa | 77 (62.6%) | 38 (30.9%) | 8 (6.5%) | < 0.01 |
≥ 7.1 kPa | 70 (21.3%) | 118 (35.9%) | 141 (42.9%) | |
First LSM | ||||
< 9.2 kPa | 114 (54.2%) | 73 (34.8%) | 23 (11.0%) | < 0.01 |
≥ 9.2 kPa | 33 (13.6%) | 83 (34.3%) | 126 (52.1%) | |
First LSM | ||||
< 13 kPa | 128 (46.7%) | 106 (38.7%) | 40 (14.6%) | < 0.01 |
≥ 13 kPa | 19 (10.7%) | 50 (28.1%) | 109 (61.2%) |